Combining Gram stain and 16S qPCR improved diagnostic accuracy for suspected pneumonia and could become a new metric in the rapid diagnosis of lower respiratory tract infections.

Autor: Hamza YP; Hamad Medical Corporation, Doha, Qatar.; Annamalai University, Rajah Muthiah Medical College, Chidambaram, India., Kacem MABH; Hamad Medical Corporation, Doha, Qatar., Al Molawi NH; Hamad Medical Corporation, Doha, Qatar., Yassine HM; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar., AlKhatib HAM; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar., Benslimane F; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar., Al-Remaihi HIKB; Hamad Medical Corporation, Doha, Qatar., El Kahlout RA; Hamad Medical Corporation, Doha, Qatar., El Kahlout BIA; Hamad Medical Corporation, Doha, Qatar., Al Khalili H; Hamad Medical Corporation, Doha, Qatar., Al Khalili MA; Hamad Medical Corporation, Doha, Qatar., Doiphode SH; Hamad Medical Corporation, Doha, Qatar., Elmagboul EBI; Hamad Medical Corporation, Doha, Qatar.; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar., Akhter J; Hamad Medical Corporation, Doha, Qatar., Al Kuwari EAE; Hamad Medical Corporation, Doha, Qatar., Coyle PV; Hamad Medical Corporation, Doha, Qatar.; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.

Publikováno v: Journal of medical microbiology [J Med Microbiol] 2024 Aug; Vol. 73 (8).

Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settings.

Autor: Coyle PV; Hamad Medical Corporation, Doha, Qatar.; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK., Al Molawi NH; Hamad Medical Corporation, Doha, Qatar., Kacem MABH; Hamad Medical Corporation, Doha, Qatar., El Kahlout RA; Hamad Medical Corporation, Doha, Qatar., Al Kuwari E; Hamad Medical Corporation, Doha, Qatar., Al Khal A; Hamad Medical Corporation, Doha, Qatar., Gillani I; Hamad Medical Corporation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Saeb H; Ministry of Public Health, Doha, Qatar., Al Thani M; Ministry of Public Health, Doha, Qatar., Bertollini R; Ministry of Public Health, Doha, Qatar., Abdul Rahim HF; College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar., Tang P; Sidra Medicine, Doha, Qatar., Latif AN; Hamad Medical Corporation, Doha, Qatar., Al Kaabi S; Hamad Medical Corporation, Doha, Qatar., Al Maslamani MARS; Hamad Medical Corporation, Doha, Qatar.; Present address: Hamad Medical Corporation, Doha, Qatar., Morris BD; Hamad Medical Corporation, Doha, Qatar., Al-Ansari N; Hamad Medical Corporation, Doha, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar., Abu Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Publikováno v: Journal of medical microbiology [J Med Microbiol] 2022 May; Vol. 71 (5).

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar.

Autor: Benslimane FM; Biomedical Research Center, Qatar University, Doha, Qatar., Al Khatib HA; Biomedical Research Center, Qatar University, Doha, Qatar., Al-Jamal O; Biomedical Research Center, Qatar University, Doha, Qatar., Albatesh D; Biomedical Research Center, Qatar University, Doha, Qatar., Boughattas S; Biomedical Research Center, Qatar University, Doha, Qatar., Ahmed AA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Bensaad M; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Younuskunju S; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Mohamoud YA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Al Badr M; National Reference Laboratory Ministry of Public Health, Doha, Qatar., Mohamed AA; National Reference Laboratory Ministry of Public Health, Doha, Qatar., El-Kahlout RA; Hamad Medical Corporation, Doha, Qatar., Al-Hamad T; Qatar Biobank, Doha, Qatar., Elgakhlab D; Qatar Biobank, Doha, Qatar., Al-Kuwari FH; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Saad C; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Al-Khal A; Hamad Medical Corporation, Doha, Qatar., Al-Maslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Bertollini R; Ministry of Public Health, Doha, Qatar., Al-Kuwari EA; Hamad Medical Corporation, Doha, Qatar., Al-Romaihi HE; Ministry of Public Health, Doha, Qatar., Al-Marri S; Ministry of Public Health, Doha, Qatar., Al-Thani M; Ministry of Public Health, Doha, Qatar., Badji RM; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Mbarek H; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Al-Sarraj Y; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Malek JA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar., Ismail SI; Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, United States.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Doha, Qatar., Coyle PV; Hamad Medical Corporation, Doha, Qatar., Thani AAA; Biomedical Research Center, Qatar University, Doha, Qatar., Yassine HM; Biomedical Research Center, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Nov 17; Vol. 11, pp. 768883. Date of Electronic Publication: 2021 Nov 17 (Print Publication: 2021).

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.

Autor: Coyle PV; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, BT7 1NN United Kingdom., Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, P.O. Box 24144, Qatar., Ben Hadj Kacem MA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Abdulla Al Molawi NH; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., El Kahlout RA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Gilliani I; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Younes N; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Anssari GAAA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Kanaani Z; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Khal A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Al Kuwari E; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Butt AA; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA., Jeremijenko A; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Latif AN; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Shaik RM; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar., Abdul Rahim HF; College of Health Sciences, QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Nasrallah GK; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Yassine HM; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Al Kuwari MG; Primary Health Care Corporation, Doha, P.O. Box 26555, Qatar., Al Romaihi HE; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Al-Thani MH; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Bertollini R; Ministry of Public Health, Doha, P.O. Box 42, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, P.O. Box 24144, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.

Publikováno v: IScience [iScience] 2021 Jun 25; Vol. 24 (6), pp. 102646. Date of Electronic Publication: 2021 May 24.